Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2022

Nov 10, 2022

284_dirs_2022-11-10_6ec5430a-ec53-4960-a1aa-956ed9917ba0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2022-11-09

Reporting Person: Oosthuizen Johannes Jacobus (President, U.S. Market)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-11-09 Common Stock S 1795 $103.21 Disposed 16730.881 Direct

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.